Skip to content

Exploratory study of test food on postprandial serum metabolite level

Exploratory study of test food on postprandial serum metabolite level - Exploratory study of test food on postprandial serum metabolite level

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053769
Enrollment
12
Registered
2026-03-01
Start date
2024-03-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Sponsors

Meiji Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Male subjects ranging age from 20 to 59 (2) Subjects who can ingest 100g test food (3) Subjects who can give informed consent to participate in this study, after being provided with an explanation of the protocol detail.

Exclusion criteria

Exclusion criteria: (1) Subjects who are now under medication treatment or will take medication on the test day (2) Subjects who are now under other clinical trials with some kind of medicine/food, or participated in those tests within four weeks before this trial, or planning to join those after the consent. (3) Subjects who regularly consume large amount of alcohol (4) Subjects with a history of gastrointestinal surgery (5) Subjects who have been diagnosed with gastroptosis or esophagitis (6) Subjects who have tested positive for HBs antigen, HCV antibody, HIV, or syphilis in the past (7) Subjects with current and/or previous medical history of serious diseases in heart, liver, kidney, digestive system, etc. (8) Subjects whose protein intake is restricted under the supervision of a doctor (9) Subjects who are aware of lactose intolerance (10) Subjects who are allergic to foods or pharmaceuticals. (11) Subjects who donated their blood components and/or whole blood (200 mL) within a month prior to this trial. (12) Subjects who donated their whole blood (400 mL) within the last three months prior to this trial. (13) Subjects who will be collected in total of their blood (1200 mL) within the last twelve months, after adding the blood amounts planning to be sampled in this trial. (14) Others who have been determined as ineligible for participation, judging from the principal/sub investigator's opinions.

Design outcomes

Primary

MeasureTime frame
Concentration of amino acids metabolites in blood

Secondary

MeasureTime frame
Concentration of free amino acids and lactic acid in blood

Countries

Japan

Contacts

Public ContactMakoto Ichinohe

CPCC Company Limited Clinical Planning Department

cpcc-contact@cpcc.co.jp03-6225-9001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026